Johnson & Johnson approaches FDA for the approval of ; Covid-19 vaccine

▴ Johnson & Johnson approaches FDA for the approval of ; Covid-19 vaccine
J&J applies for the approval of one shot vaccine developed by the company

Johnson & Johnson on Thursday (Feb. 4) officially asked the US Food and Drug Administration for an emergency-use authorization of its COVID-19 vaccine. This would be the third vaccine in the country, joining the vaccines made by Pfizer and Moderna.

“Today’s submission for Emergency Use Authorization of our investigational single-shot Covid-19 vaccine is a pivotal step toward reducing the burden of disease for people globally and putting an end to the pandemic,” Dr. Paul Stoffels, chief scientific officer at Johnson & Johnson, said in a statement.

CNN reports that as the FDA looks at testing results from Johnson & Johnson’s vaccine, it will schedule a meeting of its Vaccines and Related Biological Products Advisory Committee.

If the FDA authorizes the vaccine, the CDC’s Advisory Committee on Immunization Practices will meet to discuss whether the vaccine should be given and if so, who should get it first.

CNN reports the Johnson & Johnson vaccine is delivered in a single shot and in a global trial, was shown to be 66 percent effective in preventing moderate to severe disease.

“The vaccine is 85% effective overall at preventing hospitalization and death in all regions where it was tested,” CNN reports.

The national news outlet says the US government has already ordered 100 million doses of the vaccine, a commitment, Johnson & Johnson said it can meet by June.

Story Source

https://www.kwch.com/2021/02/04/johnson-johnson-asks-fda-to-authorize-its-covid-19-vaccine/ 

Tags : #JohnsonJohnson #FDA #CDC #CovidVaccine #OneShotCovidVaccine #PaulStoffels #USCovidNews #CNN

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026